Mark moved to Cipla Medpro Head Office as Chief Financial Officer in November 2012. He played a key role in the 100% acquisition by Cipla Limited (India) of the Cipla Medpro group in South Africa and the de-listing from the JSE which was concluded in July 2013.  

 Prior to the CFO role, Mark was the Company Secretary for the group and Financial Director of the manufacturing division (based in Durban) from 2008. He also held the position of Corporate Finance Executive and was responsible for the capital raising exercise for the factory upgrade and the sale of the non-core businesses in 2007. This is Mark’s 8th year with Cipla Medpro and he is a chartered accountant and holds a B.Com (Hons) degree from the University of Natal, Pietermaritzburg. Prior to joining Cipla Medpro, Mark was a manager in the Corporate Finance and Auditing departments at KPMG. During his time he was part of the team that worked on the acquisition of Cipla Medpro Holdings Proprietary Limited by Enaleni Pharmaceuticals Limited (now Cipla Medpro) and the listing of Cipla Medpro on the JSE in 2005.